Recurrent primary biliary cirrhosis after liver transplantation

M. G. Silveira, J. A. Talwalkar, Keith Lindor, R. H. Wiesner

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for recurrent PBC (rPBC) reported by individual LT programs range between 9% and 35%. The diagnostic hallmark of rPBC is histologic identification of granulomatous changes. Clinical and biochemical features are frequently absent with rPBC and cannot be used alone for diagnostic purposes. Some of the risk factors of rPBC may include recipient factors such as age, gender, HLA status and immunosuppression, as well as donor factors such as age, gender and ischemic time, although controversy exists. Most patients have early stage disease at the time of diagnosis, and there may be a role for therapy with ursodeoxycholic acid. While short- and medium-term outcomes remain favorable, especially if compared to patients transplanted for other indications, continued follow-up may identify reduced long-term graft and patient survival.

Original languageEnglish (US)
Pages (from-to)720-726
Number of pages7
JournalAmerican Journal of Transplantation
Volume10
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Biliary Liver Cirrhosis
Liver Transplantation
Ursodeoxycholic Acid
Graft Survival
Immunosuppression
Tissue Donors
Therapeutics

Keywords

  • Autoimmune liver disease
  • Calcineurin inhibition
  • OLT
  • Orthotopic liver transplant
  • Recurrent disease

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Recurrent primary biliary cirrhosis after liver transplantation. / Silveira, M. G.; Talwalkar, J. A.; Lindor, Keith; Wiesner, R. H.

In: American Journal of Transplantation, Vol. 10, No. 4, 04.2010, p. 720-726.

Research output: Contribution to journalArticle

Silveira, M. G. ; Talwalkar, J. A. ; Lindor, Keith ; Wiesner, R. H. / Recurrent primary biliary cirrhosis after liver transplantation. In: American Journal of Transplantation. 2010 ; Vol. 10, No. 4. pp. 720-726.
@article{db3d7bc4b8a44dfdb63e4bb2250b5249,
title = "Recurrent primary biliary cirrhosis after liver transplantation",
abstract = "Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for recurrent PBC (rPBC) reported by individual LT programs range between 9{\%} and 35{\%}. The diagnostic hallmark of rPBC is histologic identification of granulomatous changes. Clinical and biochemical features are frequently absent with rPBC and cannot be used alone for diagnostic purposes. Some of the risk factors of rPBC may include recipient factors such as age, gender, HLA status and immunosuppression, as well as donor factors such as age, gender and ischemic time, although controversy exists. Most patients have early stage disease at the time of diagnosis, and there may be a role for therapy with ursodeoxycholic acid. While short- and medium-term outcomes remain favorable, especially if compared to patients transplanted for other indications, continued follow-up may identify reduced long-term graft and patient survival.",
keywords = "Autoimmune liver disease, Calcineurin inhibition, OLT, Orthotopic liver transplant, Recurrent disease",
author = "Silveira, {M. G.} and Talwalkar, {J. A.} and Keith Lindor and Wiesner, {R. H.}",
year = "2010",
month = "4",
doi = "10.1111/j.1600-6143.2010.03038.x",
language = "English (US)",
volume = "10",
pages = "720--726",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Recurrent primary biliary cirrhosis after liver transplantation

AU - Silveira, M. G.

AU - Talwalkar, J. A.

AU - Lindor, Keith

AU - Wiesner, R. H.

PY - 2010/4

Y1 - 2010/4

N2 - Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for recurrent PBC (rPBC) reported by individual LT programs range between 9% and 35%. The diagnostic hallmark of rPBC is histologic identification of granulomatous changes. Clinical and biochemical features are frequently absent with rPBC and cannot be used alone for diagnostic purposes. Some of the risk factors of rPBC may include recipient factors such as age, gender, HLA status and immunosuppression, as well as donor factors such as age, gender and ischemic time, although controversy exists. Most patients have early stage disease at the time of diagnosis, and there may be a role for therapy with ursodeoxycholic acid. While short- and medium-term outcomes remain favorable, especially if compared to patients transplanted for other indications, continued follow-up may identify reduced long-term graft and patient survival.

AB - Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for recurrent PBC (rPBC) reported by individual LT programs range between 9% and 35%. The diagnostic hallmark of rPBC is histologic identification of granulomatous changes. Clinical and biochemical features are frequently absent with rPBC and cannot be used alone for diagnostic purposes. Some of the risk factors of rPBC may include recipient factors such as age, gender, HLA status and immunosuppression, as well as donor factors such as age, gender and ischemic time, although controversy exists. Most patients have early stage disease at the time of diagnosis, and there may be a role for therapy with ursodeoxycholic acid. While short- and medium-term outcomes remain favorable, especially if compared to patients transplanted for other indications, continued follow-up may identify reduced long-term graft and patient survival.

KW - Autoimmune liver disease

KW - Calcineurin inhibition

KW - OLT

KW - Orthotopic liver transplant

KW - Recurrent disease

UR - http://www.scopus.com/inward/record.url?scp=77949872097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949872097&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2010.03038.x

DO - 10.1111/j.1600-6143.2010.03038.x

M3 - Article

C2 - 20199502

AN - SCOPUS:77949872097

VL - 10

SP - 720

EP - 726

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 4

ER -